Houman Ashrafian - Sanofi
Houman Ashrafian is responsible for bolstering Sanofi’s pipeline of tranformative medicines and vaccines in support of its emergence as a science-driven and innovation leader in industry.
Houman Ashrafian - Sanofi - LinkedIn
View Houman Ashrafian’s profile on LinkedIn, a professional community of 1 billion members. After completing his undergraduate degree at the University of Cambridge, Houman received… ·...
- 500+ 连接数
- 位置: Sanofi
Sanofi names VC leader Houman Ashrafian as R&D chief
4 天之前 · Sanofi has made an interesting choice for its new head of R&D, turning to Houman Ashrafian, who has deep expertise in the biopharma industry, but can also draw on his most recent role as...
Meet Our Executive Leadership Team - Sanofi
Get to know the executive leaders at Sanofi who drive innovation, commitment, and success across our global healthcare endeavors.
Sanofi taps Houman Ashrafian as R&D chief, alters executive …
2023年8月31日 · Sanofi made a slew of appointments to its executive committee, the company announced Thursday. Notable among them is the appointment of Houman Ashrafian as EVP, head of R&D. He succeeds John Reed, who left for a position at Johnson & …
Houman Ashrafian - Sitryx
Houman joined SV in 2016 as a Venture Partner, was promoted to Managing Partner in 2018 and became a Scientific Advisor in 2023 following his appointment to Sanofi as Executive Vice President, Head of Research and Development.
Achieving R&D Excellence to Shape the Medicines of Tomorrow
4 天之前 · Houman Ashrafian, Executive Vice President and Head of R&D and Mike Quigley, Chief Scientific Officer, and Head of Research, reflect on an impactful year and share their vision for the future. Breakthrough Moments in 2024. For Mike Quigley, excellence in research is rooted in scientific rigor, a truth-seeking mindset and effective risk ...
Sanofi names Houman Ashrafian as R&D chief, appoints head of …
2023年8月31日 · Six months after John Reed made a surprise exit, Sanofi has zeroed in on a new head of R&D, recruiting a biotech builder out of SV Health Investors. Houman Ashrafian ...
Sanofi appoints a venture investor to R&D head as executive team ...
2023年8月31日 · Houman Ashrafian, currently a scientific advisor at SV Health Investors, will fill the role left by John Reed, who oversaw the transformation of research and development during his five years at Sanofi.
Houman Ashrafian — Radcliffe Department of Medicine
Visiting Professor of Experimental Therapeutics. Cardiac metabolism and function are inextricably linked. Maintaining energy flux is essential to the functioning of the heart which requires more energy (ATP) per gram of tissue than any other organ.